Avalo Therapeutics, Inc. Income Statement
AVTX|9 years of annual SEC 10-K data (FY2017-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 9 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$59,000
FY2025
Gross Profit
N/A
FY2025
Operating Income
-$73M
FY2025
Net Income
-$78M
FY2025
Avalo Therapeutics, Inc. reported $59,000 in revenue and $78M in net loss for FY2025. Revenue has declined at a 53.7% compound annual rate over the past 8 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -3.59 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Negative return on equity: -94.2% ROE
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59.0K | $441.0K | $1.9M | $18.1M | $5.4M | $6.7M | $6.8M | $7.0M | $27.8M |
| Cost of Revenue | - | - | $1.3M | $3.4M | $1.5M | $300.0K | -$566.5K | $3.3M | $635.6K |
| SG&A Expense | $22.9M | $17.2M | $10.3M | $20.7M | $24.7M | $17.4M | $10.1M | $10.5M | $7.9M |
| R&D Expense | $50.1M | $24.4M | $13.8M | $31.3M | $59.8M | $32.2M | $11.8M | $5.8M | $4.4M |
| Operating Income | -$72.9M | -$68.5M | -$27.4M | -$37.4M | -$82.1M | -$72.8M | -$16.1M | -$35.4M | $13.9M |
| Income Tax | $165.0K | $114.0K | $14.0K | $28.0K | -$196.0K | -$2.8M | $280.3K | -$49.5K | $2.0M |
| Net Income | -$78.3M | -$35.1M | -$31.5M | -$41.7M | -$84.4M | -$63.5M | -$16.1M | -$40.1M | $11.9M |
| EPS (Basic) | -$7.94 | -$113.58 | -$1063.00 | -$4.43 | - | - | - | $0.42 | -$4.71 |
| EPS (Diluted) | -$20.91 | -$113.58 | -$1063.00 | -$4.43 | - | - | -$1.20 | $0.42 | -$4.71 |
| Shares Outstanding | 10.5M | 801.7K | 39.3K | 9.4M | 75.0M | 44.4M | 40.8M | 31.3M | 9.4M |
| Operating Margin | -123601.7% | -15535.6% | -1421.6% | -207.4% | -1521.6% | -1087.4% | -239.1% | -503.4% | 49.9% |
| Profit Margin | -132642.4% | -7965.8% | -1639.5% | -230.8% | -1563.1% | -947.9% | -238.1% | -569.9% | 42.7% |